Other Non-current Assets - Narrative (Details) $ in Thousands	3 Months Ended			12 Months Ended
	Mar. 31, 2025 USD ($) payment	Mar. 31, 2024 USD ($)	Jun. 30, 2020 USD ($) payment	Dec. 31, 2024 USD ($) payment
Acquired Finite-Lived Intangible Assets [Line Items]
Revenues	$ 8,720	$ 12,053
Number of guaranteed royalty payments | payment			8
License agreement with Sunovion Pharmaceuticals, Inc.
Acquired Finite-Lived Intangible Assets [Line Items]
Minimum annual royalty receivable			$ 1,000
Number of annual royalty payments receivable | payment	4			4
Royalty
Acquired Finite-Lived Intangible Assets [Line Items]
Revenues	$ 0			$ 1,008
Royalty | License agreement with Sunovion Pharmaceuticals, Inc.
Acquired Finite-Lived Intangible Assets [Line Items]
Revenues			$ 8,000